Earnings Feed
Start Free
Home/Filings/4/0001209191-09-020658
4//SEC Filing

SCHWARTZ JOHN J 4

Accession 0001209191-09-020658

CIK 0000883975other
View on SEC.govCompany Profile

Filed

Apr 5, 8:00 PM ET

Accepted

Apr 6, 7:46 PM ET

Size

48.5 KB

Accession

0001209191-09-020658

Insider Transaction Report

Form 4
Period: 2009-04-02
STEMCELLS INCSTEM
SCHWARTZ JOHN J
Director
Transactions
  • Exercise/Conversion

    Stock Option (right to buy)

    2009-04-02−554→ 0 total
    Exercise: $0.25Exp: 2012-02-12→ Common Stock (554 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2009-04-02−1,261→ 0 total
    Exercise: $0.25Exp: 2012-07-18→ Common Stock (1,261 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2009-04-02−6,503→ 0 total
    Exercise: $0.25Exp: 2013-12-31→ Common Stock (6,503 underlying)
  • Exercise/Conversion

    Common Stock

    2009-04-02$0.25/sh+88,164$22,041→ 88,164 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2009-04-02−573→ 0 total
    Exercise: $0.25Exp: 2011-11-02→ Common Stock (573 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2009-04-02−2,701→ 0 total
    Exercise: $0.25Exp: 2011-12-31→ Common Stock (2,701 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2009-04-02−4,654→ 0 total
    Exercise: $0.25Exp: 2012-03-31→ Common Stock (4,654 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2009-04-02−2,143→ 0 total
    Exercise: $0.25Exp: 2013-03-21→ Common Stock (2,143 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2009-04-02−7,624→ 0 total
    Exercise: $0.25Exp: 2013-06-30→ Common Stock (7,624 underlying)
  • Sale

    Common Stock

    2009-04-02$1.67/sh−88,164$147,666→ 0 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2009-04-02−628→ 0 total
    Exercise: $0.25Exp: 2012-02-20→ Common Stock (628 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2009-04-02−852→ 0 total
    Exercise: $0.25Exp: 2012-05-02→ Common Stock (852 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2009-04-02−17,500→ 0 total
    Exercise: $0.25Exp: 2012-09-30→ Common Stock (17,500 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2009-04-02−1,667→ 0 total
    Exercise: $0.25Exp: 2013-01-14→ Common Stock (1,667 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2009-04-02−6,387→ 0 total
    Exercise: $0.25Exp: 2012-06-28→ Common Stock (6,387 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2009-04-02−2,459→ 0 total
    Exercise: $0.25Exp: 2012-09-16→ Common Stock (2,459 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2009-04-02−1,429→ 0 total
    Exercise: $0.25Exp: 2002-10-24→ Common Stock (1,429 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2009-04-02−1,613→ 0 total
    Exercise: $0.25Exp: 2012-12-19→ Common Stock (1,613 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2009-04-02−10,417→ 0 total
    Exercise: $0.25Exp: 2012-12-31→ Common Stock (10,417 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2009-04-02−12,500→ 0 total
    Exercise: $0.25Exp: 2013-03-31→ Common Stock (12,500 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2009-04-02−6,699→ 0 total
    Exercise: $0.25Exp: 2003-09-30→ Common Stock (6,699 underlying)
Footnotes (1)
  • [F1]Non-qualified option granted as compensation for service on the issuer's Board of Directors and for attendance at Board meetings. Non-employee directors have sometimes received compensation in the form of options to purchase shares of the issuer's common stock at below market prices ($0.25 per share), in lieu of cash payments of $4,500 quarterly ($8,750 quarterly for service of the Chairman of the Board), $1,500 per Board meeting attended in person or by videoconference and $500 per meeting attended by telephone. The number of shares for each such option grant was calculated using the closing price of the issuer's common stock for the date of a Board meeting or, with respect to the quarterly retainer payments, the closing price for the last business day of the quarter, less the option price of $0.25 per share. The options so issued were fully vested upon issuance.

Documents

1 file

Issuer

STEMCELLS INC

CIK 0000883975

→
Entity typeother

Related Parties

1
  • filerCIK 0001230629

Filing Metadata

Form type
4
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 7:46 PM ET
Size
48.5 KB
View on SEC.gov